Silencing Mediator for Retinoid and Thyroid Hormone Receptors Interacts with Octamer Transcription Factor-1 and Acts as a Transcriptional Repressor

Tomoko Kakizawa, Takahide Miyamoto, Kazuo Ichikawa, Teiji Takeda, Satoru Suzuki, Junichiro Mori, Mieko Kumagai, Koh Yamashita, Kiyoshi Hashizume

Journal of Biological Chemistry · 2001 · 36 citations · 37 references

DOIFull text

Open access

Concepts

Abstract

Octamer transcription factor-1 (Oct-1) is a member of the POU (Pit-1, Oct-1,unc-86) family of transcription factors and is involved in the transcriptional regulation of a variety of gene expressions related to cell cycle regulation, development, and hormonal signals. It has been shown that Oct-1 acts not only as a transcriptional activator but also as a transcriptional repressor for certain genes. The mechanism of the repressive function of Oct-1 has not been well understood. Here we demonstrate by using the glutathione S-transferase pull-down assays and coimmunoprecipitation assays that the POU domain of Oct-1 directly interacts with a silencing mediator for retinoid and thyroid hormone receptors (SMRT). The interaction surfaces are located in the C-terminal region of SMRT, which are different from previously described silencing domains I and II or receptor interacting domains I and II. In transient transfection assays in COS1 cells, overexpression of SMRT attenuated the augmentation of Oct-1 transcriptional activity by OBF-1/OCA-B, activator for Oct-1. In pull-down assays, increasing amounts of SMRT could compete the binding of OCA-B to Oct-1 POU domain. The activity of Oct-1 could be determined by a regulated balance between SMRT and OCA-B. Furthermore, cotransfected unliganded thyroid hormone receptor enhanced the transactivation by Oct-1, and addition of 3,3′,5-tri-iodo-l-thyronine obliterated the stimulatory effects. Consequently, in the presence of cotransfected thyroid hormone receptor, the octamer response element acts as an element negatively regulated by 3,3′,5-tri-iodo-l-thyronine. The results suggest that the transcriptional activity of Oct-1 can be modulated by interaction through its POU domain by a silencing mediator SMRT resulting in the cross-talk between Oct-1 and nuclear receptors. Octamer transcription factor-1 (Oct-1) is a member of the POU (Pit-1, Oct-1,unc-86) family of transcription factors and is involved in the transcriptional regulation of a variety of gene expressions related to cell cycle regulation, development, and hormonal signals. It has been shown that Oct-1 acts not only as a transcriptional activator but also as a transcriptional repressor for certain genes. The mechanism of the repressive function of Oct-1 has not been well understood. Here we demonstrate by using the glutathione S-transferase pull-down assays and coimmunoprecipitation assays that the POU domain of Oct-1 directly interacts with a silencing mediator for retinoid and thyroid hormone receptors (SMRT). The interaction surfaces are located in the C-terminal region of SMRT, which are different from previously described silencing domains I and II or receptor interacting domains I and II. In transient transfection assays in COS1 cells, overexpression of SMRT attenuated the augmentation of Oct-1 transcriptional activity by OBF-1/OCA-B, activator for Oct-1. In pull-down assays, increasing amounts of SMRT could compete the binding of OCA-B to Oct-1 POU domain. The activity of Oct-1 could be determined by a regulated balance between SMRT and OCA-B. Furthermore, cotransfected unliganded thyroid hormone receptor enhanced the transactivation by Oct-1, and addition of 3,3′,5-tri-iodo-l-thyronine obliterated the stimulatory effects. Consequently, in the presence of cotransfected thyroid hormone receptor, the octamer response element acts as an element negatively regulated by 3,3′,5-tri-iodo-l-thyronine. The results suggest that the transcriptional activity of Oct-1 can be modulated by interaction through its POU domain by a silencing mediator SMRT resulting in the cross-talk between Oct-1 and nuclear receptors. octamer transcription factor-1 thyroid hormone receptor silencing mediator for retinoid and thyroid hormone receptors nuclear hormone receptor corepressor glutathione S-transferase 3,3′,5tri-iodo-l-thyronine Pit-1, Oct-1, unc-86 trichostatin A Oct-binding factor 1 Oct-1-associated coactivator phosphate-buffered saline polyacrylamide gel electrophoresis polyvinylidene difluoride receptor interacting domain silencing domain Octamer transcription factor-1 (Oct-1)1 activates the octamer motif containing gene promoters that are ubiquitously as well as tissue-specifically expressed genes such as histone H2B, the small nuclear RNA, and Ig (1Fletcher C. Heintz N. Roeder R.G. Cell. 1987; 51: 773-781Abstract Full Text PDF PubMed Scopus (305) Google Scholar, 2Sturm R.A. Das G. Herr W. Genes Dev. 1988; 2: 1582-1599Crossref PubMed Scopus (477) Google Scholar, 3Murphy S. Yoon J.B. Gerster T. Roeder R.G. Mol. Cell. Biol. 1992; 12: 3247-3261Crossref PubMed Scopus (150) Google Scholar). Oct-1 is a member of a family of transcription factors characterized by the presence of a bipartite DNA-binding domain (POU domain). The POU domain consists of two conserved regions, a POU-specific domain and a POU homeodomain (4Herr W. Sturm R.A. Clerc R.G. Corcoran L.M. Baltimore D. Sharp P.A. Ingraham H.A. Rosenfeld M.G. Finney M. Ruvkun G. Genes Dev. 1988; 2: 1513-1516Crossref PubMed Scopus (602) Google Scholar, 5Sturm R.A. Herr W. Nature. 1988; 336: 601-604Crossref PubMed Scopus (203) Google Scholar). The both subdomains have a helix-turn-helix motif, acting not only as a DNA-binding domain but also as a protein-protein interaction domain. A number of transcription factors have been identified to interact with the POU domains of Oct-1 such as TBP, TFIIB, HMG2, and Oct-binding factor 1 (OBF-1) also referred to as Oct-1-associated coactivator (OCA-B) (6Zwilling S. Annweiler A. Wirth T. Nucleic Acids Res. 1994; 22: 1655-1662Crossref PubMed Scopus (78) Google Scholar, 7Zwilling S. Konig H. Wirth T. EMBO J. 1995; 14: 1198-1208Crossref PubMed Scopus (217) Google Scholar, 8Nakshatri H. Nakshatri P. Currie R.A. J. Biol. Chem. 1995; 270: 19613-19623Abstract Full Text Full Text PDF PubMed Scopus (60) Google Scholar, 9Gstaiger M. Georgiev O. van Leeuwen H. van der Vliet P. Schaffner W. EMBO J. 1996; 15: 2781-2790Crossref PubMed Scopus (124) Google Scholar, 10Strubin M. Newell J.W. Matthias P. Cell. 1995; 80: 497-506Abstract Full Text PDF PubMed Scopus (351) Google Scholar, 11Luo Y. Roeder R.G. Mol. Cell. Biol. 1995; 15: 4115-4124Crossref PubMed Scopus (250) Google Scholar). It has been shown that Oct-1 interacts with nuclear hormone receptors such as retinoid X receptor, thyroid hormone receptor (TR), and glucocorticoid receptor and influences their transcriptional activity (12Kutoh E. Stromstedt P.E. Poellinger L. Mol. Cell. Biol. 1992; 12: 4960-4969Crossref PubMed Scopus (89) Google Scholar, 13Chandran U.R. Warren B.S. Baumann C.T. Hager G.L. DeFranco D.B. J. Biol. Chem. 1999; 274: 2372-2378Abstract Full Text Full Text PDF PubMed Scopus (74) Google Scholar, 14Kakizawa T. Miyamoto T. Ichikawa K. Kaneko A. Suzuki S. Hara M. Nagasawa T. Takeda T. Mori J. Kumagai M. Hashizume K. J. Biol. Chem. 1999; 274: 19103-19108Abstract Full Text Full Text PDF PubMed Scopus (38) Google Scholar). Oct-1 possesses not only transactivation function but also repression function; von Willebrand factor promoter (15Schwachtgen J.L. Remacle J.E. Janel N. Brys R. Huylebroeck D. Meyer D. Kerbiriou-Nabias D. Blood. 1998; 92: 1247-1258Crossref PubMed Google Scholar), prolactin gene promoter (16Subramaniam N. Cairns W. Okret S. J. Biol. Chem. 1998; 273: 23567-23574Abstract Full Text Full Text PDF PubMed Scopus (67) Google Scholar), or rGH promoter (14Kakizawa T. Miyamoto T. Ichikawa K. Kaneko A. Suzuki S. Hara M. Nagasawa T. Takeda T. Mori J. Kumagai M. Hashizume K. J. Biol. Chem. 1999; 274: 19103-19108Abstract Full Text Full Text PDF PubMed Scopus (38) Google Scholar) was shown to be down-regulated by Oct-1. However, the mechanism of the bifunctional transcriptional activity of Oct-1 was not fully understood. OCAB/OBF-1 has been shown to be involved in the transcriptional activation by Oct-1, whereas the factor mediating the repressor function has not been isolated (15Schwachtgen J.L. Remacle J.E. Janel N. Brys R. Huylebroeck D. Meyer D. Kerbiriou-Nabias D. Blood. 1998; 92: 1247-1258Crossref PubMed Google Scholar, 16Subramaniam N. Cairns W. Okret S. J. Biol. Chem. 1998; 273: 23567-23574Abstract Full Text Full Text PDF PubMed Scopus (67) Google Scholar). Silencing mediator for retinoid and thyroid hormone receptors (SMRT) and the nuclear hormone receptor corepressor (N-CoR) were identified as interacting proteins for unliganded nuclear receptors that repress the basal transcriptional activity of target genes (17Chen J.D. Evans R.M. Nature. 1995; 377: 454-457Crossref PubMed Scopus (1712) Google Scholar, 18Horlein A.J. Naar A.M. Heinzel T. Torchia J. Gloss B. Kurokawa R. Ryan A. Kamei Y. Soderstrom M. Glass C.K. Rosenfeld M.G. Nature. 1995; 377: 397-404Crossref PubMed Scopus (1712) Google Scholar). These corepressors associate with hinge domain of nuclear receptors. It has been demonstrated that SMRT and N-CoR directly interact with mSin3 and recruit the histone deacetylases (HDAC1/Rpd3) to form a multisubunit complex to modify the chromatin template of target genes (19Heinzel T. Lavinsky R.M. Mullen T.M. Soderstrom M. Laherty C.D. Torchia J. Yang W.M. Brard G. Ngo S.D. Davie J.R. Seto E. Eisenman R.N. Rose D.W. Glass C.K. Rosenfeld M.G. Nature. 1997; 387: 43-48Crossref PubMed Scopus (1084) Google Scholar). SMRT/N-CoR functions as an adapter to link unliganded receptor heterodimers with mSin3A and HDAC1 to create a hormone-sensitive multimeric repressor complex that lead the chromatin to be transcriptionally inactive (20Nagy L. Kao H.Y. Chakravarti D. Lin R.J. Hassig C.A. Ayer D.E. Schreiber S.L. Evans R.M. Cell. 1997; 89: 373-380Abstract Full Text Full Text PDF PubMed Scopus (1107) Google Scholar). Interestingly, it has been recently shown that SMRT/N-CoR interacts with various nonreceptor transcription factors, such as oncoprotein PLZF (21Hong S.H. David G. Wong C.W. Dejean A. Privalsky M.L. Proc. Natl. Acad. Sci. U. S. A. 1997; 94: 9028-9033Crossref PubMed Scopus (305) Google Scholar, 22Lin R.J. Nagy L. Inoue S. Shao W. Miller Jr., W.H. Evans R.M. Nature. 1998; 391: 811-814Crossref PubMed Scopus (981) Google Scholar), acute myeloid leukemia-associated protein ETO (23Wang J. Hoshino T. Redner R.L. Kajigaya S. Liu J.M. Proc. Natl. Acad. Sci. U. S. A. 1998; 95: 10860-10865Crossref PubMed Scopus (456) Google Scholar, 24Gelmetti V. Zhang J. Fanelli M. Minucci S. Pelicci P.G. Lazar M.A. Mol. Cell. Biol. 1998; 18: 7185-7191Crossref PubMed Scopus (430) Google Scholar, 25Lutterbach B. Westendorf J.J. Linggi B. Patten A. Moniwa M. Davie J.R. Huynh K.D. Bardwell V.J. Lavinsky R.M. Rosenfeld M.G. Glass C. Seto E. Hiebert S.W. Mol. Cell. Biol. 1998; 18: 7176-7184Crossref PubMed Scopus (370) Google Scholar), activating protein 1 (AP-1), nuclear factor-κB (26Lee S.K. Kim J.H. Lee Y.C. Cheong J. Lee J.W. J. Biol. Chem. 2000; 275: 12470-12474Abstract Full Text Full Text PDF PubMed Scopus (114) Google Scholar), and TBL1 (27Guenther M.G. Lane W.S. Fischle W. Verdin E. Lazar M.A. Shiekhattar R. Genes Dev. 2000; 14: 1048-1057PubMed Google Scholar). Furthermore, previous studies demonstrated that several homeodomain proteins such as Pit-1 and Pbx1 functionally interact with N-CoR/SMRT resulted in a formation of the repressor complex (28Xu L. Lavinsky R.M. Dasen J.S. Flynn S.E. McInerney E.M. Mullen T.M. Heinzel T. Szeto D. Korzus E. Kurokawa R. Aggarwal A.K. Rose D.W. Glass C.K. Rosenfeld M.G. Nature. 1998; 395: 301-306Crossref PubMed Scopus (248) Google Scholar, 29Asahara H. Dutta S. Kao H.Y. Evans R.M. Montminy M. Mol. Cell. Biol. 1999; 19: 8219-8225Crossref PubMed Scopus (130) Google Scholar). These results suggested that N-CoR/SMRT possesses transcriptional repression activity for multiple transcriptional factors. In this study, we have shown that SMRT physically interacts with POU domain of Oct-1 and is involved in transcriptional repression by Oct-1. Our results illustrate a novel mechanism by which Oct-1 regulates genes both negatively and positively. These results indicate that SMRT and N-CoR are involved in a wide array of biological processes and signaling pathways. The Oct-1 expression vector pcDNA3HA Oct-1 was a gift from Dr. H. Singh (30Shah P.C. Bertolino E. Singh H. EMBO J. 1997; 16: 7105-7117Crossref PubMed Scopus (66) Google Scholar). The in vitro transcription and translation vector for Oct-1 p6His Oct-1 and OCA-B expression vector pRc OCA-B were from Dr. R. G. Roeder (11Luo Y. Roeder R.G. Mol. Cell. Biol. 1995; 15: 4115-4124Crossref PubMed Scopus (250) Google Scholar, 31Inamoto S. Segil N. Pan Z.Q. Kimura M. Roeder R.G. J. Biol. Chem. 1997; 272: 29852-29858Abstract Full Text Full Text PDF PubMed Scopus (71) Google Scholar). The OBF-1 expression vector pcDNA OBF-1 was a gift from Dr. P. Matthias (10Strubin M. Newell J.W. Matthias P. Cell. 1995; 80: 497-506Abstract Full Text PDF PubMed Scopus (351) Google Scholar). The pBS Oct-1+ was a gift from Dr. W. Herr (2Sturm R.A. Das G. Herr W. Genes Dev. 1988; 2: 1582-1599Crossref PubMed Scopus (477) Google Scholar). The eukaryotic GST expression plasmid for Oct-1 POU domain, POU homeodomain, and POU-specific domain was a gift from Dr. P. C. van der Vliet (32Coenjaerts F.E. van Oosterhout J.A. van der Vliet P.C. EMBO J. 1994; 13: 5401-5409Crossref PubMed Scopus (44) Google Scholar). The SMRT cDNA was a gift from Dr. R. M. Evans (17Chen J.D. Evans R.M. Nature. 1995; 377: 454-457Crossref PubMed Scopus (1712) Google Scholar). To construct the bacterial expression vector for GST fusion proteins, polymerase chain reaction amplified fragments were cloned into EcoRI and XhoI or SalI restriction sites of pGEX-6P1 vector (Amersham Pharmacia Biotech). Following oligonucleotides were used to amplify the full-length SMRT: forward primer, ′-gaattc ATGGAGGCATGGGACGCC-3′; reverse primer, 5′-ctcgagCTCGCTGTCGGAGAGTGT-3′; SMRT I: forward primer, 5′-gaattc ATGGAGGCATGGGACGCC-3′; reverse primer, 5′-gtcgac CTCGTAGCAGGCACGTT-3′; SMRT II: forward primer, 5′-gaattcGAGAGCCTGAAGAGCCGGC-3′; reverse primer, 5′-ctcgagGTGGCGGCTGCTGAAGGGC-3′; SMRT III: forward primer, 5′-gaattcCAGCCCTTCAGCAGCCG-3′; reverse primer, 5′-ctcgag CGAGGGCTGGCTCTCAG-3′; and SMRT IV: forward primer, 5′-gaattcGTGTCCCCACCGGAGGG-3′; reverse primer, 5′-ctcgagCTCGCTGTCGGAGAGTGT-3′. TRα1 expression vector pCDM TRα1 was described previously (33Nakai A. Sakurai A. Bell G.I. DeGroot L.J. Mol. Endocrinol. 1988; 2: 1087-1092Crossref PubMed Scopus (92) Google Scholar). The octamer sites containing reporter plasmids 8xOcta-Luc and 8xOcta/mut-Luc were gifts from Dr. P. Matthias (34Sauter P. Matthias P. Mol. Cell. Biol. 1998; 18: 7397-7409Crossref PubMed Scopus (64) Google Scholar). The pGL3-IgH promoter -luciferase reporter was a gift from Dr. R. G. Roeder (35Luo Y. Ge H. Stevens S. Xiao H. Roeder R.G. Mol. Cell. Biol. 1998; 18: 3803-3810Crossref PubMed Scopus (43) Google Scholar). COS1 cells were grown in Dulbecco's modified Eagle's medium supplemented with 10% fetal calf serum, 100 units/ml penicillin, and 0.25 mg/ml streptomycin at 37 C in 5% CO2. Transfection was done in COS1 cells using the cells were in to reporter was cotransfected with of the expression of the medium the cells was with of or of was to the medium were for reporter activity was determined by the using and expressed as to the amounts of transfection was in and the S.D. of repression of Oct-1 response Oct-1 and SMRT expression were cotransfected into COS1 cells with 0.25 of reporter with or of expression in the or presence of are transfection was in and the S.D. of in the SMRT was in vitro translation and with GST or POU domain The in vitro was in was 10% of SMRT was The the of transcription and translation of Oct-1, SMRT were using a in vitro to the of the GST fusion or GST plasmid was for and with of were and with were in containing and was by The fusion protein or the GST protein was to (Amersham Pharmacia and with containing proteins were used for interaction In vitro proteins were for at with containing of GST proteins in of binding 100 10% 1 1 1 1 1 mg/ml was in the binding with binding proteins were in of and by gel electrophoresis The results of the in vitro and the proteins by GST were and using a COS1 cells were in to transfection at a of The of was by addition of amounts of the expression were with of expression for SMRT with Oct-1 or vector using cells were with and with Dulbecco's modified Eagle's medium containing 10% fetal calf and for were to the previously described T. Ichikawa K. Hashizume K. Y. Takeda T. M. Suzuki S. T. PubMed Scopus Google Scholar). two with phosphate-buffered cells were by of 1 1 1 1 to the nuclear were by at for were in of A 1 1 1 1 1 by a at were at for were with the for at C a by the addition of of protein for 1 at were with A. The proteins were in by gel and to at 100 for 1 at C with a of containing protein from were in containing 5% for to binding of by of in The were in and for 1 with an in two in was with the (Amersham Pharmacia to the were with the was by the in 100 for at C. To the interaction between Oct-1 and SMRT, we used the fusion protein of with Oct-1 vitro pull-down shown in in vitro SMRT with POU domain but not GST and not of protein The domain and homeodomain amounts of the binding to the it was that the of SMRT to Oct-1 was not to the presence of pull-down was to the interaction between Oct-1 and the domains in SMRT that interact with Oct-1. of of GST fusion proteins of SMRT 1 were expressed in and used to full-length Oct-1. shown in 1 the domain of SMRT was for the The interacting of SMRT with Oct-1 is from the nuclear receptor interacting domains or silencing domains and which are to interact with the nuclear receptor with SMRT were also was with GST of SMRT In with previous (17Chen J.D. Evans R.M. Nature. 1995; 377: 454-457Crossref PubMed Scopus (1712) Google Scholar), of were with and whereas with was To the interaction between Oct-1 and SMRT the cells, were using COS1 cells cotransfected with SMRT Oct-1 expression shown in SMRT was by in the presence of Oct-1, the interaction between Oct-1 and SMRT the In the of Oct-1, of the amounts of Oct-1, interaction with SMRT could not be in this between SMRT and Oct-1 COS1 cells were with of expression for SMRT with Oct-1 or vector using cell were with Oct-1 by to a and with SMRT To the of SMRT in Oct-1 transcriptional we transient transfection in COS1 Oct-1 expression or expression were cotransfected with reporter plasmids containing of the Oct-1 response element into COS1 shown in of SMRT the reporter activity by was of the transcription was in with previous (10Strubin M. Newell J.W. Matthias P. Cell. 1995; 80: 497-506Abstract Full Text PDF PubMed Scopus (351) Google Scholar, 11Luo Y. Roeder R.G. Mol. Cell. Biol. 1995; 15: 4115-4124Crossref PubMed Scopus (250) Google Scholar). in the presence of cotransfected OBF-1/OCA-B, SMRT the transcriptional activation by Oct-1. In expression of Oct-1 SMRT not the reporter that repression by SMRT was through Oct-1 we the of SMRT a Oct-1 response element using Ig promoter in COS1 shown in of Oct-1 and the The expression of SMRT the Oct-1 transcriptional activity promoter in the presence or of but the These results suggested that SMRT could function as a corepressor for of the interaction of SMRT with Oct-1. SMRT has been shown to recruit histone deacetylases and through interaction with These histone deacetylases are to be involved in the function of unliganded nuclear receptors. To the by Oct-1 through SMRT, we the of a the transcriptional activity of Oct-1 M. M. M. T. J. Biol. Chem. Full Text PDF PubMed Google Scholar). shown in of COS1 cells with the by cotransfected Oct-1 and of the presence of Oct-1 and SMRT, the promoter activity in in the of cotransfected Oct-1 and In the These results suggested that histone be involved in the transcriptional SMRT interacts with and acts as a nuclear receptor we that of the transcriptional activity of Oct-1 by of the of SMRT from Oct-1. this is the of SMRT from the amounts of SMRT that can be to Oct-1, resulting in the transcriptional repression of Oct-1 we the of overexpression of and addition of Oct-1 shown in as we unliganded enhanced the transcriptional activation of by Oct-1 and addition of obliterated the that the promoter regulated by Oct-1 as a promoter through the mechanism that To the mechanism that can SMRT from Oct-1, we the pull-down shown in unliganded the of SMRT that with Oct-1 POU domain. of which the SMRT from and the number of SMRT for the interaction with Oct-1, the between SMRT and Oct-1. SMRT and OCA-B interacts with the POU the balance of the amounts of SMRT and OCA-B the bifunctional transcriptional activity of Oct-1. To SMRT and to Oct-1 the of SMRT the interaction between Oct-1 and OCA-B were using pull-down shown in addition of increasing amounts of SMRT results in binding of OCA-B to Oct-1. These suggested that SMRT and compete for binding to Oct-1 POU domain. In this study, we have the interaction between SMRT and POU domain of Oct-1. Our results that Oct-1 with SMRT by protein-protein interaction and to the of histone deacetylases complex to the resulting in the transcriptional Furthermore, as shown in SMRT and coactivator could interact with Oct-1 POU domain. Oct-1 it activates the transcription of Oct-1 response of SMRT the Oct-1 from transcriptional activator to It was previously that the POU transcription factor Pit-1 or the proteins can interact with both protein containing coactivator complex and N-CoR/SMRT containing corepressor complex and the transcriptional activity by balance between we the that the activity of Oct-1 is also determined by a regulated balance between SMRT and The SMRT interaction was located in POU domain of Oct-1. The POU domain has been shown to be involved in protein-protein interaction as well as A number of transcription factors have been identified to interact with the POU domains of Oct-1, TBP, TFIIB, HMG2, OBF-1/OCA-B, and nuclear hormone receptors such as retinoid X receptor, and glucocorticoid receptor, receptor (6Zwilling S. Annweiler A. Wirth T. Nucleic Acids Res. 1994; 22: 1655-1662Crossref PubMed Scopus (78) Google Scholar, 7Zwilling S. Konig H. Wirth T. EMBO J. 1995; 14: 1198-1208Crossref PubMed Scopus (217) Google Scholar, 8Nakshatri H. Nakshatri P. Currie R.A. J. Biol. Chem. 1995; 270: 19613-19623Abstract Full Text Full Text PDF PubMed Scopus (60) Google Scholar, 9Gstaiger M. Georgiev O. van Leeuwen H. van der Vliet P. Schaffner W. EMBO J. 1996; 15: 2781-2790Crossref PubMed Scopus (124) Google Scholar, 10Strubin M. Newell J.W. Matthias P. Cell. 1995; 80: 497-506Abstract Full Text PDF PubMed Scopus (351) Google Scholar, 11Luo Y. Roeder R.G. Mol. Cell. Biol. 1995; 15: 4115-4124Crossref PubMed Scopus (250) Google Scholar, R. W. L. R.J. J. Biol. Chem. 1999; 274: Full Text Full Text PDF PubMed Scopus Google Scholar). transcription factors interact with Oct-1 POU domain and of Oct-1. SMRT, which was cloned as a factor mediating the transcriptional repression of unliganded nuclear directly interacts with hinge domain of receptors through its C-terminal region resulting in the of the histone deacetylases (HDAC1/Rpd3) to the receptors. was also to be involved in the interaction with homeodomain transcription factors, Pit-1 and (28Xu L. Lavinsky R.M. Dasen J.S. Flynn S.E. McInerney E.M. Mullen T.M. Heinzel T. Szeto D. Korzus E. Kurokawa R. Aggarwal A.K. Rose D.W. Glass C.K. Rosenfeld M.G. Nature. 1998; 395: 301-306Crossref PubMed Scopus (248) Google Scholar, 29Asahara H. Dutta S. Kao H.Y. Evans R.M. Montminy M. Mol. Cell. Biol. 1999; 19: 8219-8225Crossref PubMed Scopus (130) Google Scholar). However, results demonstrated that SMRT a different domain the for the interaction with Oct-1, the that be certain in SMRT for interacting factors. In this we that of unliganded to the of transactivation by Oct-1, and this was by addition of the that SMRT to the Oct-1 could be by unliganded The pull-down assays demonstrated that amounts of SMRT were from Oct-1 by unliganded thyroid hormone and addition of the SMRT to Oct-1. These that the Oct-1 element as a with Oct-1. we and have that nuclear receptors such as retinoid X receptor, receptor, glucocorticoid receptor, receptor, and receptor interact with POU domain of Oct-1 and the transcriptional activity of nuclear receptors (12Kutoh E. Stromstedt P.E. Poellinger L. Mol. Cell. Biol. 1992; 12: 4960-4969Crossref PubMed Scopus (89) Google Scholar, R. W. L. R.J. J. Biol. Chem. 1999; 274: Full Text Full Text PDF PubMed Scopus Google Scholar). results suggest that SMRT the cross-talk between Oct-1 and nuclear resulting in a formation of complex transcriptional Dr. W. Dr. H. for Oct-1 Dr. P. C. van der Vliet for expression plasmids for Oct-1 POU domain, POU homeodomain, and POU-specific domain. also R. M. Evans for SMRT Dr. Matthias for 8xOcta-Luc and OBF-1 and Dr. R. G. Roeder for pGL3-IgH and OCA-B

References

37